Correction: Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Allelic Variants Relate to Shifts in Faecal Microbiota of Cystic Fibrosis Patients

Correction: Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Allelic Variants Relate to Shifts in Faecal Microbiota of Cystic Fibrosis Patients

Bibliographic Details
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2013-01-01
Series:	PLoS ONE
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3894134/?tool=EBI

Similar Items

Correction: Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Allelic Variants Relate to Shifts in Faecal Microbiota of Cystic Fibrosis Patients.
by: Serena Schippa, et al.
Published: (2013-01-01)

Cystic fibrosis transmembrane conductance regulator (CFTR) allelic variants relate to shifts in faecal microbiota of cystic fibrosis patients.
by: Serena Schippa, et al.
Published: (2013-01-01)

Cystic fibrosis transmembrane conductance regulator (CFTR): beyond cystic fibrosis
by: Giuseppe Fabio Parisi, et al.
Published: (2022-05-01)

Cystic fibrosis transmembrane conductance regulator (CFTR)-targeted therapeutics for cystic fibrosis
by: Veselu, D-F, et al.
Published: (2024)

The Cystic Fibrosis Transmembrane Regulator (CFTR) in the kidney
by: MARCELO M. MORALES, et al.
Published: (2000-09-01)

Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Ubiquitylation as a Novel Pharmaceutical Target for Cystic Fibrosis
by: Ryosuke Fukuda, et al.
Published: (2020-04-01)

Localization of the cystic fibrosis transmembrane conductance regulator (Cftr) to mouse chromosome 6.
by: Siegel, D, et al.
Published: (1992)

Relating the disease mutation spectrum to the evolution of the cystic fibrosis transmembrane conductance regulator (CFTR).
by: Lavanya Rishishwar, et al.
Published: (2012-01-01)

Cystic fibrosis transmembrane conductance regulator modulators in cystic fibrosis: current perspectives
by: Schmidt BZ, et al.
Published: (2016-09-01)

Glycosylation and the cystic fibrosis transmembrane conductance regulator
by: Glick Mary Catherine, et al.
Published: (2001-08-01)

Cholesterol Interaction Directly Enhances Intrinsic Activity of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR)
by: Stephanie Chin, et al.
Published: (2019-07-01)

Bacterial Sphingomyelinase is a State-Dependent Inhibitor of the Cystic Fibrosis Transmembrane conductance Regulator (CFTR)
by: B. B. Stauffer, et al.
Published: (2017-06-01)

Sphingosine-1-Phosphate Is a Novel Regulator of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Activity.
by: Firhan A Malik, et al.
Published: (2015-01-01)

Paediatric Thoracic Imaging in Cystic Fibrosis in the Era of Cystic Fibrosis Transmembrane Conductance Regulator Modulation
by: Patrick W. O’Regan, et al.
Published: (2024-02-01)

Targeting a genetic defect: cystic fibrosis transmembrane conductance regulator modulators in cystic fibrosis
by: Nico Derichs
Published: (2013-03-01)

Distribution of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Mutations in a Cohort of Patients Residing in Palestine.
by: Issa Siryani, et al.
Published: (2015-01-01)

Acquired cystic fibrosis transmembrane conductance regulator dysfunction
by: Catherine Banks, et al.
Published: (2018-09-01)

Structure and function of the cystic fibrosis transmembrane conductance regulator
by: M.M. Morales, et al.
Published: (1999-08-01)

Differential thermostability and response to cystic fibrosis transmembrane conductance regulator (CFTR) potentiators of human and mouse F508del-CFTR
by: Bose, S, et al.
Published: (2019)

Anti-Inflammatory Influences of Cystic Fibrosis Transmembrane Conductance Regulator Drugs on Lung Inflammation in Cystic Fibrosis
by: Kiera H. Harwood, et al.
Published: (2021-07-01)

Lung Inflammatory Genes in Cystic Fibrosis and Their Relevance to Cystic Fibrosis Transmembrane Conductance Regulator Modulator Therapies
by: Annalucia Carbone, et al.
Published: (2023-10-01)

A Developmental Role of the Cystic Fibrosis Transmembrane Conductance Regulator in Cystic Fibrosis Lung Disease Pathogenesis
by: Elena N. Huang, et al.
Published: (2021-10-01)

Cystic fibrosis transmembrane conductance regulator biomarkers in ‘real life’: can we evaluate individual efficacy of cystic fibrosis transmembrane conductance regulator therapy?
by: Silke van Koningsbruggen-Rietschel, et al.
Published: (2015-08-01)

'CFTR-opathies': disease phenotypes associated with cystic fibrosis transmembrane regulator gene mutations
by: Knowles Michael R, et al.
Published: (2001-08-01)

Characterization of defects in ion transport and tissue development in cystic fibrosis transmembrane conductance regulator (CFTR)-knockout rats.
by: Katherine L Tuggle, et al.
Published: (2014-01-01)

A protocol for identifying the binding sites of small molecules on the cystic fibrosis transmembrane conductance regulator (CFTR) protein
by: Onofrio Laselva, et al.
Published: (2022-06-01)

The mitochondrial complex I activity is reduced in cells with impaired cystic fibrosis transmembrane conductance regulator (CFTR) function.
by: Angel G Valdivieso, et al.
Published: (2012-01-01)

A transistor model for the cystic fibrosis transmembrane conductance regulator
by: William D. Hunt, et al.
Published: (2023-06-01)

Corneal Refractive Surgery Considerations in Patients with Cystic Fibrosis and Cystic Fibrosis Transmembrane Conductance Regulator-Related Disorders
by: Moshirfar M, et al.
Published: (2022-11-01)

The effect of cystic fibrosis transmembrane conductance regulator modulators on impaired glucose tolerance and cystic fibrosis related diabetes
by: Sana Hasan, et al.
Published: (2022-09-01)

Effectiveness and Safety of Cystic Fibrosis Transmembrane Conductance Regulator Modulators in Children With Cystic Fibrosis: A Meta-Analysis
by: Qiyu Li, et al.
Published: (2022-06-01)

Cystic Fibrosis Transmembrane Conductance Regulator Genotype, Not Circulating Catecholamines, Influences Cardiovascular Function in Patients with Cystic Fibrosis
by: Alexander L Bisch, et al.
Published: (2019-03-01)

Cystic Fibrosis Transmembrane Conductance Regulator Folding Mutations Reveal Differences in Corrector Efficacy Linked to Increases in Immature Cystic Fibrosis Transmembrane Conductance Regulator Expression
by: Kathryn W. Peters, et al.
Published: (2021-10-01)

A randomised, double-blind, placebo-controlled trial of repeated nebulisation of non-viral cystic fibrosis transmembrane conductance regulator (CFTR) gene therapy in patients with cystic fibrosis
by: Alton, EWFW, et al.
Published: (2016)

A randomised, double-blind, placebo-controlled trial of repeated nebulisation of non-viral cystic fibrosis transmembrane conductance regulator (CFTR) gene therapy in patients with cystic fibrosis
by: Eric WFW Alton, et al.
Published: (2016-07-01)

State of the Art on Approved Cystic Fibrosis Transmembrane Conductance Regulator (<i>CFTR</i>) Modulators and Triple-Combination Therapy
by: Aniello Meoli, et al.
Published: (2021-09-01)

Raman Spectroscopy and Cystic Fibrosis Disease: An Alternative Potential Tool for Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Modulator Response Differentiation—A Pilot Study Based on Serum Samples
by: Giuseppe Acri, et al.
Published: (2024-01-01)

A Proteomic Survey of the Cystic Fibrosis Transmembrane Conductance Regulator Surfaceome
by: Melissa Iazzi, et al.
Published: (2023-07-01)

Cystic Fibrosis, CFTR, and Colorectal Cancer
by: Patricia Scott, et al.
Published: (2020-04-01)

Lack of correlation between pulmonary disease and cystic fibrosis transmembrane conductance regulator dysfunction in cystic fibrosis: a case report
by: Cleveland Robert H, et al.
Published: (2010-04-01)